What might its impact really be in Europe?

M. Muers (Leeds, United Kingdom)

Source: Annual Congress 2005 - A sceptical look at lung cancer screening
Session: A sceptical look at lung cancer screening
Session type: Symposium
Number: 4414
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Muers (Leeds, United Kingdom). What might its impact really be in Europe?. Annual Congress 2005 - A sceptical look at lung cancer screening

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What you have to show before you do a screening programme
Source: Annual Congress 2005 - A sceptical look at lung cancer screening
Year: 2005

The impact of a lung cancer computed tomography screening result on smoking abstinence
Source: Eur Respir J 2011; 37: 1466-1473
Year: 2011



Impact of genetic factors on lung development in health and disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=93
Year: 2006

Epidemiology, social and health-status impact
Source: Annual Congress 2005 - PG13 - COPD: genetic and environmental factors, epidemiology, socio-economic impact and preventative measures
Year: 2005


The approach to the surgical management of cancer in four European countries
Source: Eur Respir J 2003; 22: 838-844
Year: 2003



Effects of childhood smoking on respiratory symptoms
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005


Early detection of COPD is important for lung cancer surveillance
Source: Eur Respir J 2012; 39: 1230-1240
Year: 2012



Women and lung cancer: potential mechanisms of greater susceptibility to tobacco smoke
Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=146
Year: 2003

Current situation of a smoking cessation and lung cancer screening programme in a Spanish third level hospital
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


Screening
Source: Eur Respir J 2003; 21: 3S-15S
Year: 2003



How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis?
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012


The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey
Source: ERJ Open Res, 6 (1) 00158-2019; 10.1183/23120541.00158-2019
Year: 2020



COPD prevalence is increased in lung cancer, independent of age, sex and smoking history
Source: Eur Respir J 2009; 33: 380-386
Year: 2009



A case-control study of lifestyle risk factors associated with tuberculosis in Liverpool, North-West England
Source: Eur Respir J 2001; 18: 959-964
Year: 2001



The costs of smoking and the economics of smoking cessation
Source: Eur Respir Mon; 2008: 42: 23–34
Year: 2008

Is there a health benefit of reduced tobacco consumption? A sytematic review
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006


Cannabis use and risk of lung cancer: a case-control study
Source: Eur Respir J 2008; 31: 280-286
Year: 2008



Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020
Year: 2020



The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Source: Eur Respir J 2002; 20: 464-479
Year: 2002



Preliminary results of the impact of a French randomized feasibility trial of lung cancer screening on the quality of life, risk perception and smoking status: étude Dépiscan
Source: Eur Respir J 2005; 26: Suppl. 49, 486s
Year: 2005